Approvals/TGA/ARIPIPRAZOLE RBX aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit

Approved

STANDARD

ARIPIPRAZOLE RBX aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit

Sun Pharma ANZ Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c4278747e05952e8
Product Name: ARIPIPRAZOLE RBX aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit
Artg Id: 485481
Artg Name: ARIPIPRAZOLE RBX aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit
Sponsor: Sun Pharma ANZ Pty Ltd
Company Detail Path: /organization/sun-pharma-anz-pty-ltd
Artg Date: 2025-11-05
Registration Type: Medicine
Therapeutic Good Type: Medicines
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Nov 7, 2025

Approval ID

c4278747e05952e8

Type

Standard